🔎 Trials Near Me

Akèy › Dyabèt Tip 2 › Texas › Dallas

Etid klinik pou Dyabèt Tip 2 nan Dallas, TX

19 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Ap rekriteFaz 3
  • North Texas Endocrine Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Ap rekriteFaz 3
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

Ap rekrite
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
Tout laj · Tout sèks · Mizajou Sep 29, 2026 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Ap rekriteFaz 2
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Ap rekriteFaz 2
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 11, 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

Ap rekriteFaz 2
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Ap rekriteFaz 2
  • Velocity Clinical Research - Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

Ap rekriteFaz 3
  • Research Institute of Dallas, Dallas
Laj 10 a 17 · Tout sèks · Mizajou Aug 7, 2026 · NCT06739122

Polypill for Prevention of Cardiomyopathy

Ap rekriteFaz 1/2
  • UT Southwestern Medical Center, Dallas
Laj 18 a 100 · Tout sèks · Mizajou Aug 4, 2026 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Ap rekriteFaz 2
  • Zenos Clinical Research, Dallas
Laj 18 a 70 · Tout sèks · Mizajou Jun 15, 2026 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Ap rekriteFaz 2
  • Velocity Clinical Research Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Ap rekrite
  • UT Southwestern Medical Center, Dallas
Laj 18 a 60 · Tout sèks · Mizajou Feb 10, 2026 · NCT05168605

Etid Dyabèt Tip 2 nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.